MustGrow Biologics Corp. has entered into two agreements to enhance its market presence and investor awareness. The company signed a 12-month media services contract with Market One Media Group for $70,000 to distribute editorial and video content across various platforms including BNN Bloomberg. Additionally, MustGrow secured a 24-month market research agreement with GBC AG for EUR 40,000 annually to target German and European investors through sponsored content and social media. These efforts aim to support MustGrow's growth by increasing visibility of its sustainable agricultural products and technologies globally.
More than 50 companies are actively developing over 55 new drugs for pulmonary arterial hypertension (PAH), a serious lung-related heart condition. These drugs are in various clinical trial stages, with several in late-stage development, aiming to im...
MoneyFlare has introduced an AI-powered trading bot designed to automate trading in both cryptocurrency and stock markets. This tool aims to simplify automated trading by handling market monitoring, data analysis, strategy execution, and trade manage...
ImmunityBio presented data showing its ANKTIVA plus BCG treatment outperformed two FDA-approved bladder cancer therapies, Adstiladrin and INLEXZO. The ANKTIVA combo achieved a 69.7% complete response rate versus 53.4% for Adstiladrin, with a longer m...
Global Fight League (GFL) has launched a public investment campaign powered by DealMaker, allowing fans and investors to buy preferred stock and gain ownership in a new team-based MMA league. The league plans to start its inaugural season in 2026 wit...
Cava Group is set to report its Q1 2026 earnings with analysts expecting earnings per share (EPS) of $0.17, a 22.7% decline from last year's $0.22. Despite the EPS drop, revenue is projected to grow strongly by 26.1% to about $418.5 million, reflecti...
